The role of the non-depolarizing drugs in the prevention of suxamethonium bradycardia.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000731:Androstanes / Q000627:therapeutic use; D001919:Bradycardia / Q000139:chemically induced*; D004562:Electrocardiography; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D003473:Neuromuscular Nondepolarizing Agents / Q000627:therapeutic use*; D010880:Piperidines / Q000627:therapeutic use; D011292:Premedication; D013390:Succinylcholine / Q000009:adverse effects*; D014117:Toxiferine / Q000627:therapeutic use; D014403:Tubocurarine / Q000627:therapeutic use
D000731:Androstanes; D003473:Neuromuscular Nondepolarizing Agents; D010880:Piperidines; D014117:Toxiferine; D013390:Succinylcholine; D014403:Tubocurarine